AI can be applied to patient data in real time, allowing medical reviewer teams to actively monitor patient safety, with the AI alerting medical review teams to identify potential adverse events (AEs), data anomalies, critical issues for patients on treatment, and more.
Related Posts
Phase II NIPU Trial Data Lead to FDA Fast Track Designation for Cancer Vaccine in Mesothelioma Treatment
Mesothelial cells in body fluid sample. Image credit: toeytoey | stock.adobe.com The FDA has granted Fast Track Designation to Ultimovacs…
Emerging Biosimilars and the Importance of Identifying Experienced Providers
Although biologics and biosimilar drugs only represent 2% of U.S. prescription volume, these naturally sourced medications have recently become the…
The Importance of Real-World Evidence in Medical Research and Drug Development
Credit: putilov_denis | stock.adobe.com Introduction As the gold standard for clinical research, randomized controlled trials (RCTs) are central to scientific…